PGAM2 p.Arg21His
c.62G>A · rs1392611950 · VCV943301
Computational evidence
| Protein change | ||
| AlphaMissense | 0.6277 | likely pathogenic |
|---|---|---|
| REVEL | 0.692 | pathogenic-leaning |
| SaProt | LLR -11.72 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not looked up on this page · why |
| Constraint at this position | ||
| Conservation | phyloP 5.9 | GERP 1.8, phastCons 1 |
| Regional constraint | o/e 0.98 | unconstrained · MANE · 2,762 bp · p 0.7 · regional, not allelic |
| Overall | ||
| CADD | 24.7 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 0.00338% | 29,608 |
| South Asiangrpmax | 0.00329% | 30,362 |
| Admixed American | 0.00167% | 60,030 |
| European (non-Finnish) | 0.000339% | 295,005 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- PGAM2
- Protein
- p.Arg21His
- Coding
- c.62G>A
- MANE Select
- NM_001014436 · reported on NM_000290
- dbSNP
- rs1392611950
- Type
- single nucleotide variant
- Location
- chr7:44065468 (GRCh38)
Disease context
glycogen storage disease due to phosphoglycerate mutase deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Glycogen storage disease due to phosphoglycerate mutase deficiency (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Adolescent, Childhood
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pgam2-p-arg21his (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown